16-May-2023 | D | Board recommended final dividend of Re.1 /- per equity share (10% of face value of
Rs.10 /- each), out of the profits of the financial year 2022-23, subject to approval of the members of the Company, which shall be paid/ dispatched within 30 days from the
conclusion of the ensuing Annual General Meeting. | 08-Sep-2023 | |
04-Feb-2025 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Wednes | 05-Feb-2025 | |
24-Jan-2025 | BC | Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 inter alia to consider and approve unaudited standalone and consolida | 30-Jan-2025 | |
30-Oct-2024 | BC | Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2024 inter alia to consider and approve unaudited standalone and consolida | 05-Nov-2024 | |
26-Sep-2024 | BC | Appointment of Director in place of Mr. Narayan K. Seshadri, who retires by rotation and being eligible offers himself for re appointment
| 26-Sep-2024 | |
26-Sep-2024 | BC | Completion of tenure of Mr. Kummamuri Narasimha Murthy Independent Director | 25-Sep-2024 | |
Announcement Date16-May-2023
Ex Dividend Date08-Sep-2023
Dividend(%)10
No Bonus has been declared by MAXHEALTH
No Split has been declared by MAXHEALTH
RightsNo Rights has been declared by MAXHEALTH
Book Closure
05-Feb-2025 | - | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Wednes |
30-Jan-2025 | - | Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 inter alia to consider and approve unaudited standalone and consolida |
05-Nov-2024 | - | Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2024 inter alia to consider and approve unaudited standalone and consolida |
26-Sep-2024 | - | Appointment of Director in place of Mr. Narayan K. Seshadri, who retires by rotation and being eligible offers himself for re appointment
|
25-Sep-2024 | - | Completion of tenure of Mr. Kummamuri Narasimha Murthy Independent Director |